0001937993 1 2026-07-08 2026-07-08 0001937993 2026-07-08 2026-07-08 iso4217:USD pure shares S-3 EX-FILING FEES 0001937993 N/A N/A S-3 Cadrenal Therapeutics, Inc. false Equity Common Stock, $0.001 par value per share true 2942400 3.04 8944896.00 0.0001381 1235.29 8944896.00 1235.29 0.00 0.00 1235.29 Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers such an indeterminate amount of shares of common stock as may become issuable to prevent dilution resulting from stock splits, stock dividends and similar events.<br/><br/>The amount registered consists of up to 2,942,400 shares of the Registrant’s common stock held by certain selling stockholders.<br/><br/>Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on the Nasdaq Capital Market on July 10, 2026 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act).